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Summary Mastectomy probably represents over-treatment for the majority of women with screen detected ductal carcinoma in situ (DCIS)
and breast-conserving surgery is now widely advocated. In this study, biopsy cavity shavings were used to ensure complete excision in 129
women undergoing breast-conserving surgery for screen detected DCIS. A margin was considered clear if DCIS was > 1 mm from any margin
of excision and shavings were clear. Patients with involved margins (DCIS at resection margin) underwent re-excision, irrespective of shaving
status. After re-excision, 101 women (78%) had clear margins and 28 (22%) close margins (DCIS < 1 mm from resection margin). Cavity
shavings were histologically clear of DCIS in all cases. Ipsilateral DCIS recurrence occurred in 12 (9.3%) patients. Two recurrences also
contained invasive carcinoma. The median time to diagnosis was 14 months and all recurrences occurred at the site of the previous biopsy.
Seven recurrences were detected at the first annual mammogram, four at the second and one at the third. Ipsilateral recurrence was related
to margin status; only 2 out of 101 (2%) patients with clear margins recurred, compared with 10 out of 28 (36%) patients with close margins.
Local recurrence and close margin status both correlated with a high modified Van Nuys prognostic index score. Our results indicate that local
relapse represents residual DCIS rather than true recurrence in the majority of cases. Cavity shavings have proved ineffective in ensuring
complete excision. We now ensure a minimum 10 mm margin of excision around all screen-detected DCIS lesions.
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Ductal carcinoma in situ (DCIS) has become clinically important
only since the advent of routine high-quality mammography, and
now accounts for 20-25% of screen-detected breast malignancies
(Verbeek etal, 1984). The majority ofscreen detected DCIS lesions,
however, are asymptomatic and impalpable (Gump et al, 1987).
Despite the increase in diagnosis, the optimal surgical treatment
for DCIS remains controversial. Until recently, DCIS was not
differentiated from invasive breast carcinoma and was treated by
mastectomy (Price et al, 1989). Since the widespread acceptance
of breast-conserving surgery for early invasive breast cancer
however, mastectomy is becoming more difficult to justify for
localized screen-detected DCIS
The main purpose ofbreast-conserving surgery for invasive or in
situdisease is completeexcision ofthetumour (bothmacroscopically
and microscopically) with a surrounding margin of normal tissue to
prevent local recurrence, while maintaining a cosmetically accept-
ablebreast. Unfortunately, thereis noregularconsensus regardingthe
definition ofcomplete excision orofan adequate margin ofexcision.
It is clear that the margin of clearance around an invasive tumour
correlates with local control rates, with positive resection margins
being associated with an increased risk oflocal recurrence (Veronesi
et al, 1990). However, the volume of excised tissue is inversely
proportional to the cosmetic outcome (Wazeret al, 1992).
Recurrence rates after local excision ofDCIS vary widely among
different studies and may reflect the type of surgery, adequacy of
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excision margins, DCIS pathology and patient selection criteria in
each study. It is generally agreed that after local surgery up to 30%
of women with DCIS will have recurrent lesions within 15 years,
but, more importantly, up to 50% of patients will have invasive
breast carcinoma on recurrence (Price et al, 1989).
Inadequate excision of the primary lesion appears to be one of
the most important causes of local failure after breast-conserving
surgery (Silverstein et al, 1994), and new prognostic index for
DCIS has been proposed recently that includes resection margins
as one of its predictive factors (Silverstein et al, 1996). The Van
Nuys prognostic index (VNPI) also quantifies two otherpredictors
oflocal recurrence, namely DCIS size and pathological classifica-
tion. A numerical system is used to predict patients more likely to
recur after breast conserving surgery.
The histological evaluation of excision margins is now known
to be a critical part of the assessment of any patient with DCIS
being considered for breast-conserving treatment, and various
techniques have been used to improve the accuracy, including
inking of specimen margins, two-dimensional radiography, cavity
shavings and tumour bed biopsies. Biopsy cavity shavings are
routinely used in our unit after wide local excision of invasive
carcinomas to reduce the incidence ofre-excision in patients with
the tumour extending close to the main specimen margin.
The aim of this study was to determine the effectiveness of
using biopsy cavity shavings to ensure complete excision of
screen-detected DCIS lesions.
PATIENTS AND METHODS
Screening mammography is performed at the Nightingale Breast
Screening Centre, University Hospital ofSouth Manchester. Patients
with mammographic evidence of malignant microcalcification or a
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Table 1 Margin status after initial and re-excisional surgical procedures.
Clear DCIS > 1 mm from any inked margin of excision; involved, DCIS at any
inked margin of excision; close, DCIS < 1 mm from any inked margin of
excision
n Clear Involved Close
Initial biopsy
Localization biopsy 118 50 22 46
Open biopsy 11 4 3 4
Total 129 54 (41.9) 25 (19.4) 50 (38.8)
After re-excision
Localization biopsy 118 96 0 22
Open biopsy 11 5 0 6
Total 129 101 (78.3) 0 28 (21.7)
Local recurrence 12 2 (2) 0 10 (36)
Numbers in parentheses are percentages.
suspicious mass lesion were referred for a surgical opinion and treat-
ment options discussed.
Although preoperative cytology was available for patients with
palpable disease, during the early part ofthis study stereotactic fine-
needle aspiration cytology (FNAC) was in its infancy in our unit,
and the majority of patients with impalpable lesions had cytology
that was inadequate for preoperative diagnosis. Mammographic
screening detected 120 lesions, although nine women presented
with symptoms (mass, six; discharge, one; other, two).
Surgical procedures were carried out in the following manner:
women with palpable lesions corresponding to a mammographic
abnormality proceeded to open biopsy, with or without specimen
radiography; and those with impalpable lesions were initially
localized by the use of a needle, under mammographic guidance.
After the excision ofthe lesion, fourquadrant cavity-wall shavings
(range 2-5) were taken routinely. The excised specimens were
orientated with ligaclips, before being submitted to two-
dimensional compression radiography, to ensure excision of the
mammographic abnormality. If biopsy margins appeared close to
the radiological lesion, further shavings were taken from the
appropriate margin ofthe cavity.
In the histopathology laboratory, a standard protocol was
followed: main specimens and cavity shavings were measured and
then painted with India ink before sectioning, after which further
radiographs were taken of all localization biopsies. Particular
attention was paid to the margin of each biopsy, in particular in
regions ofeither gross or radiological in situ disease. Biopsy spec-
imens and their cavity shavings were blocked in their entirety.
Histopathological margin status of the main specimen was
defined as follows: clear, DCIS > 1 mm from any inked margin of
excision; involved, DCIS at any inked margin of excision; and
close, DCIS < 1 mm from any inked margin ofexcision.
Irrespective of cavity shavings, patients with involved margins
underwent formal re-excision and further cavity shavings were
taken. Patients with clear or close margins were submitted to
formal re-excision only if one or more cavity shaving contained
DCIS. Again, further cavity shavings were taken at the time of re-
excision.
After complete excision, 61 patients received adjuvant therapy,
either tamoxifen (n = 41) or breast irradiation (n = 15) or a combi-
nation ofthe two (n = 5).
Post-operatively, women were examined clinically every 3
months for the first year, and underwent two view mammography
on an annual basis. Women with mammographic suspicion of
recurrent DCIS (malignant microcalcification) underwent a further
needle localization biopsy to confirm the diagnosis. A diagnosis of
recurrent DCIS after local excision invariably led to simple
mastectomy.
Retrospectively, a modified VNPI (MVNPI) score was calcu-
lated from size score (1-3) + nuclear grade score (1-3) + margin
status score (2-3), to give each patient's DCIS lesion a score
ranging from 4 (best prognosis) to 9 (worst prognosis). In common
with the VNPI (Silverstein et al, 1996), a score of 1 was given for
lesions < 15 mm, 2 for lesions 16-40 mm and 3 for lesions
> 41 mm. Our pathological score included nuclear grade alone,
with low nuclear grade lesions scoring 1, intermediate grade
lesions 2 and high-grade lesions 3. We used a margin status score
of2 forclear (> 1 mm) margins and a score of3 forclose (< 1 mm)
margins. Statistical analysis was performed using the x2 test with
Yates' correction and the Mann-Whitney U-test.
RESULTS
During a 58-month period from January 1991 to November 1995,
a series of 129 women with localized screen-detected DCIS were
diagnosed and treated with breast-conserving surgery. Median age
at diagnosis was 57 years (range 34-78 years).
By far the commonest mammographic abnormality was micro-
calcification (113 out of 129, 87.6%); a mammographic mass
lesion was present in the remaining patients (16 out of 129,
12.4%). Clinically, 105 (81.4%) of the mammographic lesions
were considered impalpable and 24 (18.6%) palpable.
Initial surgery consisted of open biopsy in 11 patients with
clearly palpable lesions and a needle localization procedure in 118
patients. Thirteen patients with minimally palpable disease also
underwent localization. Specimen radiography confirmed excision
of the mammographic abnormality in each case. The median
weight of the main specimen was 20.5 g (range 5-61 g). The
median size (and ranges) of the main specimen was 50 mm (90-
30 mm) x 40 mm (80-20 mm) x 22 mm (40-10 mm). Cavity
shavings were measured in their maximum diameter only. Median
sizes (and range) were, superior 25 mm (45-10 mm), medial
20 mm (50-8nm), lateral 18 mm (45-9 mm), inferior 22 mm
(35-10 mm) and deep 20 mm (38-10 mm).
Histopathology revealed pure comedo DCIS in 21 out of 129
(16.3%), pure non-comedo in 31 out of 129 (24.0%) and a mixture
of comedo/non-comedo in 76 out of 129 (59.7%). Microinvasion
(invasion < 1 mm) was seen in 16 (12.4%) cases. Of these, six
(37.5%) were pure comedo, one (6.25%) non-comedo and nine
(56.25%) mixed comedo/non-comedo DCIS. Microinvasive lesions
were considered to be poorly differentiated in 15 out of 16 (93.7%)
cases and intermediately differentiated in 1 out of 16 (6.3%). The
median size of all DCIS lesions at initial biopsy was 12 mm (range
2-40 mm). One hundred and four women had close or clear
margins with no involvement ofshavings, whereas 25 had involved
margins, nine (30%) ofwhom had positive cavity shavings.
Involvement (or close proximity of DCIS) of main specimen
margins (n = 47; see Table 1) or cavity shavings (n = 9) after initial
needle localization or open biopsy led to re-excision, with further
cavity shavings being taken in each case. Margin status after initial
and re-excisional biopsy is shown in Table 1. After re-excision,
cavity shavings were reported as histologically clear ofDCIS in all
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Table 2 Relationship between modified VNPI score, close resection margin
status and local recurrence
MVNPI score n Close resection margins Local recurrence
3,4,5 25 0 0
6 56 7 (12.5) 4 (7.1)
7,8 48 21 (43.8) 8 (16.7)
Clear, DCIS > 1 mm from any inked margin of excision; involved, DCIS at any
inked margin of excision; close, DCIS < 1 mm from any inked margin of












Figure 1 Comparison of margin status with Modified Van Nuys Prognostic
Index (MVNPI) [composed of grade (1-3), size (1-3), margin status (2-3)]. The main factoraffecting the index is the margin status rather than grade or
size. Re-excision of DCIS with close margins would havedowngraded the
MVNPI score and reduced recurrence.
129 cases. Out of the 25 patients with involved margins, six had
DCIS in the re-excision specimen, all of whom originally had
positive cavity shavings. All nine women with positive cavity
shavings after the first excision had clear shavings after
re-excision, although two still had close margins.
Post-operatively, 68patients(52.7%) received noadjuvant treat-
ment, 41 (31.8%) received tamoxifen therapy alone, 15 (11.6%)
radiotherapy alone and five (3.9%) a combination of tamoxifen
and radiotherapy. Sixty-four patients were entered into the UK
DCIS trial and 34 received adjuvanttherapy. Ofthe remainder not
in the trial, 38 out of 65 women received no adjuvant therapy but
27 weregiven tamoxifen(n = 15) orradiotherapy (n = 12). Patients
have been followed up for a median 35 months (range 12-68
months) and all haveundergone their first annual mammogram.
During the study period, one patient developed histologically
confirmed carcinoma ofthe contralateral breast.
Overall, histologically confirmed ipsilateral breast recurrence
occurred in 12 out of 129(9.3%)patients. All recurrences occurred
at or near the site of the previous biopsy. Ten of these recurrences
were pure DCIS of identical/similar histological subtype to that
present in the initial biopsy. Two recurrences contained, in addi-
tion to DCIS, invasive ductal carcinoma. Of the 12 ipsilateral
recurrent lesions, median pathological size at initial biopsy was
15 mm(range 5-28 mm).
The median time to diagnosis was 14 months (range 11-40
months). Seven ipsilateral recurrences were detected at the first
annual mammogram, four at the second and one at the third. Ofthe
12 patients with ipsilateral recurrence, seven occurred in patients
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who had not received any form of adjuvant therapy and five
occurred in patients who had received post-operative tamoxifen
therapy alone.
Ipsilateral recurrence was significantly related to resection
margin status (Table 1, x2 = 25.7, P < 0.001). Of the 12 recur-
rences, ten occurred in patients with close margins, compared with
only two in patients with clear margins. Out of 20 patients given
radiotherapy, none has relapsed.
The relationship between modified VNPI score, close resection
margin status and local recurrence is shown in Table 2. Close
margin status was not associated with a score of3, 4 or 5, but was
present in 43.8% patients with a score of 7 or 8. There was no
relapse in patients with a score of3, 4 or5, butrecurrence occurred
in 16.7% ofpatients with a score of7 or 8. Close margin status was
found to correlate with a high MVNPI score (Figure 1, P < 0.001,
Mann-Whitney U-test).
DISCUSSION
Breast-conserving surgery is now widely advocated in the
management of screen-detected DCIS. The main problem with
breast conservation is local recurrence. After planned local exci-
sion of DCIS, without post-operative radiotherapy, various recur-
rence rates have been reported: 8% after a median follow up of 18
months (Silverstein et al, 1992), 15% at 4 years (Lagios et al,
1982), 23% at 39 months (Fisher et al, 1986), 55% at7 years (Price
et al, 1989), 63% at 9 years (Price etal, 1990). The numberoflocal
recurrences increases with time; Fisher's recurrence rate of23% at
39 months increased to 43% at 83 months (Fisher et al, 1991).
There is, as yet, no evidence to indicate that initial failure in local
control adversely affects survival, but local recurrence is a great
source of anxiety and psychological morbidity to the patient and
her family (Jenkins et al, 1991), in particular as the majority of
patients with recurrent DCIS are treated by mastectomy in the
United Kingdom.
For invasive breast cancers, cavity shavings and tumour bed
biopsies have been found to be useful in identifying a group of
patients who are potentially at a higher risk of local relapse after
conservative surgery and may benefit from re-excision (Macmillan
et al, 1994). In our own unit, involvement of biopsy specimen
resection margins or cavity shavings have been shown to correlate
with residual invasive or in situ disease within the conserved
breast (Walls et al, 1995). In this present study, cavity shavings
were used in an attempt to identify DCIS patients with close or
involved margins as inadequate excision of the primary lesion is
probably the most important cause of local failure after breast-
conserving surgery for DCIS (Silverstein et al, 1996).
Unfortunately, there is, as yet, no established definition of what
constitutes a clear margin of excision. The NSABP B-17 trial
(Fisher et al, 1995) was the first major randomized prospective
trial of treatment for localized DCIS. In this study, margins
were regarded as free when the tumour was not transected. Patho-
logical assessments indicating lesions to be 'close' or 'too close'
(< 1 mm) to the resection margin were not considered to represent
margin involvement. Their results have shown local recurrence
rates of 13.9% after a mean follow-up of only 24 months. Is this
relatively high incidence of local recurrence related to inadequate
excision? Studies on mastectomy specimens after a biopsy
showing DCIS have shown residual DCIS at the original biopsy
site in an average of 44% of cases (range 16-78%), (Fentiman et
al, 1986; Fisher et al, 1986; Gump et al, 1987). Histologically
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negative margins do not guarantee that residual DCIS has not been
left behind. In a study by Silverstein, 181 patients were treated by
wide local excision. Clear margins were defined as no DCIS
within 1 mm of any margin. All patients subsequently underwent
mastectomy or re-excision of the biopsy site. Not surprisingly,
76% ofpatients with initially involved margins had residual DCIS,
but so did 43% of patients initially considered to have clear
margins (Silverstein et al, 1994). These data indicate that many of
the recurrences in the NSABP Protocol B-17 trial were in fact
examples of residual disease and not true recurrences. This
hypothesis is supported by patterns of failure studies that have
shown that during the first 10 years after breast-conserving
surgery, 70-80% ofrecurrences occur within the same quadrant as
the original surgery (Kurtz et al, 1990). Furthermore, the relapse
rate of 13.9% in the NSABP B-17 trial was reduced to 5% with the
addition ofpost-operative radiotherapy (Fisher et al, 1995).
In our study, despite cavity shavings being clear in all cases, the
incidence of ipsilateral local relapse was 9.3% after a median
follow-up of only 14 months. This incidence of relapse is clearly
unsatisfactory. All recurrences occurred at or near the site of the
original biopsy and had similar or identical histological features.
Seven out of the twelve recurrences were detected by the first
annual mammogram. As our definitions of involved, close and
clear resection margins were similar to those described in the
earlier studies, there seems little doubt that our relapses represent
residual DCIS rather than true recurrence, in the majority ofcases.
The Van Nuys prognostic index (VNPI) combines three signifi-
cant predictors of local recurrence, namely margin width, tumour
size and pathological classification to predict local recurrence after
breast conserving surgery (Silverstein et al, 1996). DCIS patients
with VNPI scores of3 or 4 had a low risk oflocal relapse, whereas
patients with scores of 8 or 9 had a very high risk of local relapse.
Patients with a score of 5, 6 or 7 had an intermediate risk. The
calculation ofour modified score (MNVPI) differed from VNPI in
two ways. First, nuclear grade was the only pathological criterion
included, the presence or absence ofcomedo-type necrosis was not
assessed. Second, only two groups were included in the margin
status score. Tumours were considered completely excised if
margins were greater than 1 mm, but the exact size of these clear
margins could not be accurately assessed retrospectively. Despite
these differences, our MVNPI correlated well with the incidence
of local recurrence, but this may merely reflect the fact that
MVNPI is also strongly correlated with close margin status. We
agree with the Van Nuys group that margin status, size and histo-
logical features are the most reliable predictors of local relapse
after breast-conserving surgery, but for the majority of screen
detected DCIS cases we feel that margin status remains the most
important single factor. Tumours greater than 40 mm in size are
probably not suitable for breast conservation, irrespective of other
factors.
Why have cavity shavings proved to be an inaccurate method of
assessing complete excision of DCIS lesions in our study? The
majority of biopsies were diagnostic and United Kingdom guide-
lines exist to minimize the volume of breast tissue removed in
benign cases (Quality Assurance Guidelines for Surgeons in
Breast Cancer Screening). Initial biopsy specimens were therefore
small, the median weight of our recorded initial biopsies was only
20.5 g. To preserve cosmesis, cavity shavings were smaller than
the main specimen in the majority ofcases. In multifocal lesions at
least, the surgical margin and or cavity shavings may lie between
the tumour foci, giving the false impression of a free margin.
Increasing experience with stereotactic FNAC will allow a pre-
operative diagnosis of malignancy to be made, and enable us to
perform a therapeutic biopsy with a wider margin of excision. A
recent study has explored the three-dimensional structure of the
various types of DCIS using a stereoscopic technique (Faverly
et al, 1994). This study showed that poorly differentiated DCIS
nearly always grows continuously, although well-differentiated
DCIS usually has a multifocal distribution. In cases of true multi-
focal disease, the gaps between foci are short (< 1 cm in 83% of
cases). The authors of this study suggest that at the time of resec-
tion, a 1 cm rim of normal breast tissue should be excised around
the primary lesion. With this approach, complete excision should
be possible for approximately 90% of DCIS cases, irrespective of
histological subtype.
Complete local excision is an essential requirement before entry
into several on-going prospective trials of adjuvant therapy for
DCIS, but no guidance as to the minimum margin of excision is
given. Evidence from both this and previous studies suggest that
this might lead to inadequate local excision and high local recur-
rence rates in some cases. We feel that to accurately assess the
effect of adjuvant treatments such as tamoxifen or radiotherapy in
preventing true DCIS relapse and progression, DCIS lesions must
be completely excised. In this study, recurrence occurred in five
patients receiving adjuvant tamoxifen therapy, however in the
presence of almost certain residual disease, the efficacy of
tamoxifen as a chemopreventative agent cannot be assessed.
Most authors now agree that recurrences after local excision of
DCIS most likely reflect residual disease, and several studies
clearly suggest that 1 mm is an inadequate margin of excision
(Lagios et al, 1982; Holland et al, 1990; Silverstein et al, 1994;
1996). A tissue margin of 1-2 cm from the edge of the mammo-
graphically assessed lesion seems necessary to ensure that histo-
logical assessment of the margin is accurate. In our hands, biopsy
cavity shavings have proved to be inadequate in assessing
complete excision of screen-detected DCIS lesions using a clear
margin of excision of 1 mm. With the aid of stereotactic FNAC,
our clinical practice has now changed. We aim to perform a thera-
peutic biopsy at the initial procedure whenever possible, and
proceed to elective wider excision if DCIS is close to the main
specimen margin. We try to ensure a clear histological margin of
5-10 mm in each case; with such a margin, cavity shavings
become irrelevant.
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